Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
MagBio Launches its Novel cfKapture 21 Kit
MagBio Genomics is proud to introduce the cfKapture 21 kit, a revolutionary solution for the isolation of circulating Cell-Free DNA (ccfDNA) from stabilized plasma samples....
Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
<p>Evotec and Eternygen announced a drug discovery collaboration to develop novel metabolic disease therapy.</p> <p>The two companies will develop novel small molecule inhibitors against an Eternygen target to treat metabolic disease using Evotec’s technology platform and broad expertise in drug discovery and pre-clinical development.</p> <p>Eternygen is working on the sodium coupled citrate transporter NaCT, a novel target which is a key r...
First-of-its-kind Clinical Trial Monitoring Service Launched for Cancer Patients
<p xss=removed>Specimatch, the first continual clinical trial monitoring service announces the launch of its web-based software service for cancer patients. Users can easily connect to clinical trials personally matched to the patient’s genetic and clinical profiles through Specimatch.com.</p> <p xss=removed>This software is a solution for patients and oncologists to tap into a complex landscape of breakthrough treatments with both accuracy an...
FDA grants breakthrough therapy designation to Toca 511 & Toca FC in Recurrent High Grade Glioma
<p>Tocagen’s new gene therapeutic formulations – Toca 511 & Toca FC – for treating recurrent and metastatic cancers, specifically High-Grade Glioma (HGG), received FDA’s “breakthrough therapy designation” and awaits a full approval post clinical trials next year.</p> <p>HGG is a malignant form of primary brain tumour that originates from glial cells of the brain. Glial cells provide the structural backbone of the brain and support the funct...
Generative Adversarial Autoencoders to Revolutionize New Medications
A team of computer scientists from around the world has developed Generative Adversarial Autoencoders (AAE) as a means to generate new molecular fingerprints based on specific parameters....
Benchling Announces Release of Its Molecular Biology 2.0 to Power High-Throughput Design for DNA, Proteins & CRISPR
<p xss=removed>Benchling, the next generation life science R&D software company announces the release of the first of its kind, Molecular Biology 2.0 system, which is an exceptional extension of its existing molecular biology suite.</p> <p xss=removed>It helps to power high-throughput sequence design for DNA, proteins, and CRISPR. Molecular Biology 2.0 incorporates batch sequence design, CRISPR design, and cloning software, as well as full-fle...
FDA Approves Novartis Kisqali® Femara® Co-Pack to treat metastatic breast cancer
Novartis has received FDA approval for its Kisqali Femara Co-Pack, a combination pack of two prescription products for advanced breast cancer treatment. The Co-Pack contains ribociclib tablets and letrozole tablets, which are used to treat hormone...
Australian Scientists Discover Breakthrough in Lung Cancer Treatment
Australian scientists have achieved a significant breakthrough in the field of lung cancer treatment. They have successfully identified the source cell responsible for a common type of lung cancer that claims the lives of both smokers and non-smokers....
New Liquid Biopsy Chip Allows to Trap Cancer Cells Easily
Researchers at Worcester Polytechnic Institute (WPI) have developed an innovative chip that can effectively trap and identify metastatic cancer cells present in a small blood sample taken from a cancer patient....
Aptar Pharma and Medtech firms to Develop Novel Auto-injector
Aptar Pharma, a division of AptarGroup, has entered into an exclusive development and license agreement with BD (Becton, Dickinson and Company), a leading medtech firm, to collaboratively create an innovative auto-injector....
